These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21295879)

  • 41. Intensity modulation under geometrical uncertainty: a deconvolution approach to robust fluence.
    Fan Y; Nath R
    Phys Med Biol; 2010 Jul; 55(14):4029-45. PubMed ID: 20601776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Prostate cancer].
    Vieillot S; Fenoglietto P; Aillères N; Hay MH; Dubois JB; Azria D
    Cancer Radiother; 2010 Nov; 14 Suppl 1():S161-73. PubMed ID: 21129660
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Midline dose verification with diode in vivo dosimetry for external photon therapy of head and neck and pelvis cancers during initial large-field treatments.
    Tung CJ; Yu PC; Chiu MC; Yeh CY; Lee CC; Chao TC
    Med Dosim; 2010; 35(4):304-11. PubMed ID: 20627683
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Altered fractionation in radiotherapy: from radiobiological rationale to therapeutic gain.
    Marcu LG
    Cancer Treat Rev; 2010 Dec; 36(8):606-14. PubMed ID: 20494524
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Medical memo: high-dose radiotherapy for prostate cancer.
    Harv Mens Health Watch; 2007 Apr; 11(9):6. PubMed ID: 17441270
    [No Abstract]   [Full Text] [Related]  

  • 46. [Head and neck cancers. II. Progress in radiotherapy of head and neck cancers--with special reference to IMRT (intensity-modulated radiotherapy)].
    Akimoto T; Hanyu Y; Fukuoka M; Kurooka M; Nakamura K; Mihashi N
    Gan To Kagaku Ryoho; 2009 Jul; 36(7):1093-7. PubMed ID: 19662711
    [No Abstract]   [Full Text] [Related]  

  • 47. [Comparison between conventional radiotherapy and intensity modulated radiotherapy for head and neck cancer-effectiveness and adverse effect-].
    Kodaira T
    Gan To Kagaku Ryoho; 2011 Jul; 38(7):1103-6. PubMed ID: 21812148
    [No Abstract]   [Full Text] [Related]  

  • 48. [Utility of VMAT: Aspect of Clinical Application].
    Haga A
    Igaku Butsuri; 2016; 36(3):161-165. PubMed ID: 28442654
    [No Abstract]   [Full Text] [Related]  

  • 49. Is intensity-modulated radiotherapy for prostate cancer ready for prime-time?
    Rodrigues G
    Can J Urol; 2012 Aug; 19(4):6381-2. PubMed ID: 22892262
    [No Abstract]   [Full Text] [Related]  

  • 50. A discussion of the clinical use of advanced technologies in head and neck radiotherapy.
    Meyer JL; Eisbruch A; Le QT
    Front Radiat Ther Oncol; 2007; 40():232-238. PubMed ID: 17641512
    [No Abstract]   [Full Text] [Related]  

  • 51. Dose-Escalated Radiotherapy for Prostate Cancer: Is the Sky the Limit?
    Gray PJ; Zietman AL
    JAMA Oncol; 2015 Oct; 1(7):883-4. PubMed ID: 26181340
    [No Abstract]   [Full Text] [Related]  

  • 52. Re: Dose-Escalated Irradiation and Overall Survival in Men with Nonmetastatic Prostate Cancer.
    Taneja SS
    J Urol; 2016 Mar; 195(3):628. PubMed ID: 26887709
    [No Abstract]   [Full Text] [Related]  

  • 53. [Intensity modulated radiotherapy].
    Furuhira T
    Nihon Jibiinkoka Gakkai Kaiho; 2015 Nov; 118(11):1380-4. PubMed ID: 26897764
    [No Abstract]   [Full Text] [Related]  

  • 54. Implementation of intensity-modulated radiotherapy: lessons learned and implications for the future.
    Cooper T; Williams MV
    Clin Oncol (R Coll Radiol); 2012 Oct; 24(8):539-42. PubMed ID: 22789770
    [No Abstract]   [Full Text] [Related]  

  • 55. [IMRT practice].
    Katano S
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2010 Mar; 66(3):231-7. PubMed ID: 20379064
    [No Abstract]   [Full Text] [Related]  

  • 56. Editorial Comment to Particle radiotherapy for prostate cancer.
    Yokomizo A
    Int J Urol; 2015 Jan; 22(1):39. PubMed ID: 25358663
    [No Abstract]   [Full Text] [Related]  

  • 57. Financial gain is driving referrals for specialist prostate radiotherapy, says report.
    McCarthy M
    BMJ; 2013 Aug; 347():f4978. PubMed ID: 23929905
    [No Abstract]   [Full Text] [Related]  

  • 58. Prostate cancer and the hypofractionation hypothesis.
    Lee WR
    J Clin Oncol; 2013 Nov; 31(31):3849-51. PubMed ID: 24101055
    [No Abstract]   [Full Text] [Related]  

  • 59. Reply to M.J. Brenner et al and I.R. Vogelius et al.
    Pollack A; Walker G; Horwitz EM; Price R; Feigenberg S; Konski AA; Stoyanova R; Movsas B; Greenberg RE; Uzzo RG; Ma C; Buyyounouski MK
    J Clin Oncol; 2014 Jun; 32(17):1853-4. PubMed ID: 24778402
    [No Abstract]   [Full Text] [Related]  

  • 60. In Regard to Bibault et al.
    Tallet AV; Forissier V; Fau P; Darreon J
    Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):528-529. PubMed ID: 29353661
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.